Get the Stockscreener App
1.54
1.32%
0.02
After Hours:
1.57
0.03
+1.95%
Therapeuticsmd Inc stock is traded at $1.54, with a volume of 117.56K.
It is up +1.32% in the last 24 hours and up +23.20% over the past month.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
See More
Previous Close:
$1.52
Open:
$1.47
24h Volume:
117.56K
Relative Volume:
0.60
Market Cap:
$17.59M
Revenue:
$996.00K
Net Income/Loss:
$-6.09M
P/E Ratio:
-2.9057
EPS:
-0.53
Net Cash Flow:
$-9.76M
1W Performance:
-5.81%
1M Performance:
+23.20%
6M Performance:
+2.67%
1Y Performance:
+19.38%
1-Day Range:
$1.4446
$1.5808
1-Week Range:
$1.4446
$2.10
52-Week Range:
$0.70
$2.44
Therapeuticsmd Inc Stock (TXMD) Company Profile
Name
Therapeuticsmd Inc
Sector
Phone
561-961-1900
Address
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Compare TXMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
1.54 | 17.59M | 996.00K | -6.09M | -9.76M | -0.53 |
|
ZTS
Zoetis Inc
|
118.14 | 52.35B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.07 | 44.67B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.61 | 43.10B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
VTRS
Viatris Inc
|
10.71 | 12.28B | 14.33B | -3.79B | 1.84B | -3.17 |
|
UTHR
United Therapeutics Corp
|
476.59 | 20.32B | 3.08B | 1.24B | 1.07B | 25.61 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-07-20 | Downgrade | Jefferies | Hold → Underperform |
| May-19-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-02-19 | Initiated | Guggenheim | Buy |
| Oct-17-19 | Initiated | H.C. Wainwright | Buy |
| Apr-30-19 | Resumed | Noble Capital Markets | Outperform |
| Jun-15-18 | Initiated | JP Morgan | Overweight |
| Sep-08-17 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-11-17 | Upgrade | Oppenheimer | Perform → Outperform |
| May-09-17 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-22-16 | Resumed | Jefferies | Buy |
| Nov-22-16 | Initiated | Oppenheimer | Outperform |
| Nov-07-16 | Resumed | Guggenheim | Buy |
| Apr-04-16 | Initiated | Goldman | Buy |
| Dec-08-15 | Reiterated | Jefferies | Buy |
| Dec-08-15 | Reiterated | Stifel | Buy |
| Sep-21-15 | Reiterated | Jefferies | Buy |
| Jun-09-15 | Initiated | Guggenheim | Buy |
| Jul-08-14 | Initiated | FBR Capital | Outperform |
| Apr-17-14 | Reiterated | Noble Financial | Buy |
| Jan-28-14 | Reiterated | Noble Financial | Buy |
View All
Therapeuticsmd Inc Stock (TXMD) Latest News
Will TherapeuticsMD Inc. stock beat EPS estimates2025 EndofYear Setup & Growth Focused Stock Reports - newser.com
Will TherapeuticsMD Inc. (29TA) stock hit Wall Street targets2025 Market Overview & Fast Exit/Entry Strategy Plans - newser.com
Is TherapeuticsMD Inc. stock a buy before product launchesTrade Analysis Report & Fast Momentum Entry Tips - newser.com
Is TherapeuticsMD Inc. (29TA) stock a contrarian opportunityWeekly Profit Analysis & High Yield Stock Recommendations - newser.com
Editor: 【Stock Market Forum】 - newser.com
Is TherapeuticsMD Inc. (29TA) stock supported by strong fundamentals2025 Macro Impact & AI Forecasted Stock Moves - newser.com
Can TherapeuticsMD Inc. stock hit analyst price targetsWeekly Trade Review & Daily Chart Pattern Signal Reports - newser.com
Will TherapeuticsMD Inc. (29TA) stock outperform energy sector in 2025Buy Signal & Consistent Return Investment Signals - newser.com
Can TherapeuticsMD Inc. (29TA) stock test all time highsIPO Watch & Safe Capital Preservation Plans - newser.com
How TherapeuticsMD Inc. (29TA) stock compares with tech leadersMarket Growth Report & Technical Analysis for Trade Confirmation - newser.com
Will TherapeuticsMD Inc. stock see insider buyingAnalyst Downgrade & Safe Entry Trade Signal Reports - newser.com
Trend analysis for TherapeuticsMD Inc. this weekQuarterly Portfolio Review & Entry Point Confirmation Signals - newser.com
How to manage a losing position in TherapeuticsMD Inc.2025 Trading Volume Trends & Accurate Trade Setup Notifications - newser.com
Can a trend reversal in TherapeuticsMD Inc. lead to recovery2025 Market Trends & Weekly Watchlist for Hot Stocks - newser.com
Can TherapeuticsMD Inc. stock weather global recessionPortfolio Return Summary & Reliable Volume Spike Alerts - newser.com
Why TherapeuticsMD Inc. stock remains a top recommendationJuly 2025 Market Mood & Real-Time Stock Movement Alerts - newser.com
Can TherapeuticsMD Inc. (29TA) stock hit consensus price targetsNew Guidance & Stock Market Timing Techniques - Fundação Cultural do Pará
TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors - 富途牛牛
Therapeuticsmd Inc Stock (TXMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.02%
3.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):